salvinorin a has been researched along with tivozanib in 1 studies
| Studies (salvinorin a) | Trials (salvinorin a) | Recent Studies (post-2010) (salvinorin a) | Studies (tivozanib) | Trials (tivozanib) | Recent Studies (post-2010) (tivozanib) |
|---|---|---|---|---|---|
| 247 | 7 | 128 | 105 | 23 | 100 |
| Protein | Taxonomy | salvinorin a (IC50) | tivozanib (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.0709 | |
| Fibroblast growth factor 2 | Homo sapiens (human) | 0.0709 | |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | 0.0709 | |
| Platelet-derived growth factor receptor alpha | Homo sapiens (human) | 0.0023 | |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.0032 | |
| Ephrin type-B receptor 2 | Homo sapiens (human) | 0.0175 | |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 0.0017 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.0783 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 0.07 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kabir, M; Kerns, E; Nguyen, K; Shah, P; Sun, H; Wang, Y; Xu, X; Yu, KR | 1 |
1 other study(ies) available for salvinorin a and tivozanib
| Article | Year |
|---|---|
Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.
Topics: Drug Discovery; Organic Chemicals; Pharmaceutical Preparations; Solubility | 2019 |